{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:35Z","timestamp":1761101015376},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11886-009-0028-6","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T09:45:26Z","timestamp":1241516726000},"page":"192-201","source":"Crossref","is-referenced-by-count":6,"title":["Therapy for acute heart failure syndromes"],"prefix":"10.1007","volume":"11","author":[{"given":"Sarah M.","family":"Donlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Quattromani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,6]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","volume":"112","author":"M. Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Zannad F, Sopko G, et al.: Acute heart failure syndromes: current state and framework for future research. Circulation 2005, 112:3958\u20133968.","journal-title":"Circulation"},{"key":"28_CR2","volume-title":"Heart Disease and Stroke Statistics\u20142005 Update","author":"American Heart Association","year":"2005","unstructured":"American Heart Association: Heart Disease and Stroke Statistics\u20142005 Update. Dallas, TX: American Heart Association; 2005. Available at http:\/\/www.americanheart.org\/downloadable\/heart\/1105390918119HDSStats2005Update.pdf . Accessed February 11, 2009."},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","volume":"296","author":"M. Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Abraham WT, Albert NM, et al.: Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217\u20132226.","journal-title":"JAMA"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","volume":"155","author":"G. Cotter","year":"2008","unstructured":"Cotter G, Felker GM, Adams KF, et al.: The pathophysiology of acute heart failure: is it all about fluid accumulation? Am Heart J 2008, 155:9\u201318.","journal-title":"Am Heart J"},{"key":"28_CR5","first-page":"1531","volume":"287","author":"Publication Committee for the VMAC Investigators","year":"2002","unstructured":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF): Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002, 287:1531\u20131540.","journal-title":"JAMA"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","volume":"293","author":"J.D. Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K: Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005, 293:1900\u20131905.","journal-title":"JAMA"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","volume":"111","author":"J.D. Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein JD, Skopicki HA, Aaronson KD: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487\u20131491.","journal-title":"Circulation"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"K.F. Adams Jr","year":"2005","unstructured":"Adams KF Jr, Fonarow GC, Emerman CL, et al.: Characteristics and outcomes of patients hospitalized for heart failure in the united states: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 2005, 149:209\u2013216.","journal-title":"Am Heart J"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","volume":"50","author":"G.C. Fonarow","year":"2007","unstructured":"Fonarow GC, Stough WG, Abraham WT, et al.: Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 2007, 50:768\u2013777.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","volume":"24","author":"J.G. Cleland","year":"2003","unstructured":"Cleland JG, Swedberg K, Follath F, et al.: The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003, 24:442\u2013463.","journal-title":"Eur Heart J"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.annemergmed.2007.07.007","volume":"51","author":"S. Collins","year":"2008","unstructured":"Collins S, Storrow AB, Kirk JD, et al.: Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med 2008, 51:45\u201357.","journal-title":"Ann Emerg Med"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","volume":"325","author":"J.N. Cohn","year":"1991","unstructured":"Cohn JN, Johnson G, Ziesche S, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991, 325:303\u2013310.","journal-title":"N Engl J Med"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardfail.2005.12.001","volume":"12","author":"Heart Failure Society of America","year":"2006","unstructured":"Heart Failure Society of America: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006, 12:10\u201338.","journal-title":"J Card Fail"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","volume":"50","author":"P. Levy","year":"2007","unstructured":"Levy P, Compton S, Welch R, et al.: Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med 2007, 50:144\u2013152.","journal-title":"Ann Emerg Med"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00002512-200320070-00002","volume":"20","author":"K. Moazemi","year":"2003","unstructured":"Moazemi K, Chana JS, Willard AM, Kocheril AG: Intravenous vasodilator therapy in congestive heart failure. Drugs Aging 2003, 20:485\u2013508.","journal-title":"Drugs Aging"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.amjcard.2006.11.025","volume":"99","author":"D.D. Shin","year":"2007","unstructured":"Shin DD, Brandimarte F, De Luca L, et al.: Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am J Cardiol 2007, 99:S4\u2013S23.","journal-title":"Am J Cardiol"},{"key":"28_CR17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198205133061902","volume":"306","author":"J.N. Cohn","year":"1982","unstructured":"Cohn JN, Franciosa JA, Francis GS, et al.: Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: Results of a veterans administration cooperative study. N Engl J Med 1982, 306:1129\u20131135.","journal-title":"N Engl J Med"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","volume":"52","author":"W. Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Francis GS, et al.: Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 2008, 52:200\u2013207.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR19","unstructured":"US National Institutes of Health: ASCEND-HF. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00475852 . Accessed February 11, 2009."},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","volume":"327","author":"K. Swedberg","year":"1992","unstructured":"Swedberg K, Held P, Kjekshus J, et al.: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992, 327:678\u2013684.","journal-title":"N Engl J Med"},{"issue":"SupplB","key":"28_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/15.suppl_B.14","volume":"15","author":"A. Sigurdsson","year":"1994","unstructured":"Sigurdsson A: Left ventricular remodeling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction. Eur Heart J 1994, 15(Suppl B):14.","journal-title":"Eur Heart J"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.annemergmed.2006.10.024","volume":"49","author":"S.M. Silvers","year":"2007","unstructured":"Silvers SM, Howell JM, Kosowsky JM, et al.: Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med 2007, 49:627\u2013669.","journal-title":"Ann Emerg Med"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.58.3.466","volume":"583Pt1","author":"C. Leier","year":"1978","unstructured":"Leier C, Heban PT, Huss P, et al.: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978, 58(3 Pt 1):466\u2013475.","journal-title":"Circulation"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","volume":"339","author":"D.C. Brater","year":"1998","unstructured":"Brater DC: Diuretic therapy. N Engl J Med 1998, 339:387\u2013395.","journal-title":"N Engl J Med"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardfail.2004.08.160","volume":"11","author":"C.M. O\u2019Connor","year":"2005","unstructured":"O\u2019Connor CM, Stough WG, Gallup DS, et al.: Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 2005, 11:200\u2013205.","journal-title":"J Card Fail"},{"key":"28_CR26","doi-asserted-by":"crossref","unstructured":"Salvador DR, Rey NR, Ramos GC, Punzalan FE: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005:CD003178.","DOI":"10.1002\/14651858.CD003178.pub3"},{"key":"28_CR27","first-page":"581","volume":"19","author":"D.H. Ellison","year":"1999","unstructured":"Ellison DH: Diuretic resistance: physiology and therapeutics. Semin Nephrol 1999, 19:581\u2013597.","journal-title":"Semin Nephrol"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B. Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","volume":"100","author":"H.A. Cooper","year":"1999","unstructured":"Cooper HA, Dries DL, Davis CE, et al.: Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999, 100:1311\u20131315.","journal-title":"Circulation"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"S.A. Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al.: ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154\u2013e235.","journal-title":"Circulation"},{"key":"28_CR31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"SOLVD Investigators","year":"1991","unstructured":"SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators. N Engl J Med 1991, 325:293\u2013302.","journal-title":"N Engl J Med"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0735-6757(99)90198-5","volume":"17","author":"A. Sacchetti","year":"1999","unstructured":"Sacchetti A, Ramoska E, Moakes ME, et al.: Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med 1999, 17:571\u2013574.","journal-title":"Am J Emerg Med"},{"key":"28_CR33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1378\/chest.92.4.586","volume":"92","author":"J. Hoffman","year":"1987","unstructured":"Hoffman J: Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest 1987, 92:586\u2013593.","journal-title":"Chest"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1197\/j.aem.2005.03.273","volume":"12","author":"W.F. Peacock","year":"2005","unstructured":"Peacock WF, Hollander JE, Diercks DB, et al.: Morphine for acute decompensated heart failure: valuable adjunct or a historical remnant? Acad Emerg Med 2005, 12:97\u201398.","journal-title":"Acad Emerg Med"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/HPC.0b013e318177dc74","volume":"7","author":"W.F. Peacock","year":"2008","unstructured":"Peacock WF, Fonarow GC, Ander DS, et al.: Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society Of Chest Pain Centers Acute Heart Failure Committee. Crit Pathw Cardiol 2008, 7:83\u201386.","journal-title":"Crit Pathw Cardiol"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K. Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, et al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society Of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388\u20132442.","journal-title":"Eur Heart J"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.69.1.113","volume":"69","author":"C.S. Liang","year":"1984","unstructured":"Liang CS, Sherman LG, Doherty JU, et al.: Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. Circulation 1984, 69:113\u2013119.","journal-title":"Circulation"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0009-9236(98)90092-3","volume":"63","author":"A. Elis","year":"1998","unstructured":"Elis A, Bental T, Kimchi O, et al.: Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study. Clin Pharmacol Ther 1998, 63:682\u2013685.","journal-title":"Clin Pharmacol Ther"},{"key":"28_CR39","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1067\/mhj.2001.119610","volume":"142","author":"M.H. Yamani","year":"2001","unstructured":"Yamani MH, Haji SA, Starling RC, et al.: Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact. Am Heart J 2001, 142:998\u20131002.","journal-title":"Am Heart J"},{"key":"28_CR40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/0002-8703(91)90832-3","volume":"121","author":"J.L. Anderson","year":"1991","unstructured":"Anderson JL: Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the united states. Am Heart J 1991, 121:1956\u20131964.","journal-title":"Am Heart J"},{"key":"28_CR41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","volume":"41","author":"G.M. Felker","year":"2003","unstructured":"Felker GM, Benza RL, Chandler AB, et al.: Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003, 41:997\u20131003.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9149(01)01581-8","volume":"88","author":"A.J. Burger","year":"2001","unstructured":"Burger AJ, Elkayam U, Neibaur MT, et al.: Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001, 88:35\u201339.","journal-title":"Am J Cardiol"},{"key":"28_CR43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","volume":"144","author":"A.J. Burger","year":"2002","unstructured":"Burger AJ, Horton DP, LeJemtel T, et al.: Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the precedent study. Am Heart J 2002, 144:1102\u20131108.","journal-title":"Am Heart J"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","volume":"46","author":"W.T. Abraham","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, et al.: In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE). J Am Coll Cardiol 2005, 46:57\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"28_CR45","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"M.S. Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF Jr, et al.: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541\u20131547.","journal-title":"JAMA"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-009-0028-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-009-0028-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-009-0028-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:11Z","timestamp":1559433371000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-009-0028-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s11886-009-0028-6","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}